Linus Pauling Institute

Kuiper HC, Stevens JF.  2011.  LC-MS/MS quantitation of mercapturic acid conjugates of lipid peroxidation products as markers of oxidative stress.. Curr Protoc Toxicol. Chapter 17:Unit17.14.2.

Preble I, Zhang Z, Kopp R, Garzotto M, Bobe G, Shannon J, Takata Y.  2019.  Dairy Product Consumption and Prostate Cancer Risk in the United States.. Nutrients. 11(7)

Kovacs M, Trias E, Varela V, Ibarburu S, Beckman JS, Moura IC, Hermine O, King PH, Si Y, Kwon Y et al..  2019.  CD34 Identifies a Subset of Proliferating Microglial Cells Associated with Degenerating Motor Neurons in ALS.. Int J Mol Sci. 20(16)

Fang J-B, Nikolic D, Lankin DC, Simmler C, Chen S-N, Alvarenga RFRamos, Liu Y, Pauli GF, van Breemen RB.  2019.  Formation of (2)- and (2)-8-Prenylnaringenin Glucuronides by Human UDP-Glucuronosyltransferases.. J Agric Food Chem. 67(42):11650-11656.

Harakeh S, Jariwalla RJ.  1997.  NF-kappa B-independent suppression of HIV expression by ascorbic acid.. AIDS Res Hum Retroviruses. 13(3):235-9.

Jariwalla RJ, Harakeh S.  1996.  Antiviral and immunomodulatory activities of ascorbic acid.. Subcell Biochem. 25:213-31.

Kapitonov V, Jurka J.  1996.  The age of Alu subfamilies.. J Mol Evol. 42(1):59-65.

Harakeh S, Jariwalla RJ.  1995.  Ascorbate effect on cytokine stimulation of HIV production.. Nutrition. 11(5 Suppl):684-7.

Jurka J, Pethiyagoda C.  1995.  Simple repetitive DNA sequences from primates: compilation and analysis.. J Mol Evol. 40(2):120-6.

Jurka J, Zietkiewicz E, Labuda D.  1995.  Ubiquitous mammalian-wide interspersed repeats (MIRs) are molecular fossils from the mesozoic era.. Nucleic Acids Res. 23(1):170-5.

Harakeh S, Niedzwiecki A, Jariwalla RJ.  1994.  Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus.. Chem Biol Interact. 91(2-3):207-15.

Harakeh S, Niedzwiecki A, Jariwalla RJ.  1994.  Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus.. Chem Biol Interact. 91(2-3):207-15.

Tóth G, Jurka J.  1994.  Repetitive DNA in and around translocation breakpoints of the Philadelphia chromosome.. Gene. 140(2):285-8.

Milosavljević A, Jurka J.  1993.  Discovering simple DNA sequences by the algorithmic significance method.. Comput Appl Biosci. 9(4):407-11.

Jurka J.  1993.  A new subfamily of recently retroposed human Alu repeats.. Nucleic Acids Res. 21(9):2252.

Boulikas T.  1993.  Poly(ADP-ribosyl)ation, DNA strand breaks, chromatin and cancer.. Toxicol Lett. 67(1-3):129-50.

Jurka J, Kaplan DJ, Duncan CH, Walichiewicz J, Milosavljević A, Murali G, Solus JF.  1993.  Identification and characterization of new human medium reiteration frequency repeats.. Nucleic Acids Res. 21(5):1273-9.

Leung PY, Miyashita K, Young M, Tsao CS.  1993.  Cytotoxic effect of ascorbate and its derivatives on cultured malignant and nonmalignant cell lines.. Anticancer Res. 13(2):475-80.

Boulikas T.  1992.  Homeotic protein binding sites, origins of replication, and nuclear matrix anchorage sites share the ATTA and ATTTA motifs.. J Cell Biochem. 50(2):111-23.

Jurka J, Walichiewicz J, Milosavljević A.  1992.  Prototypic sequences for human repetitive DNA.. J Mol Evol. 35(4):286-91.

Boulikas T.  1992.  Evolutionary consequences of nonrandom damage and repair of chromatin domains.. J Mol Evol. 35(2):156-80.

Leung PY, Dunham WB, Tsao CS.  1992.  Ascorbic acid with cupric ions as a chemotherapy for human lung tumor xenografts implanted beneath the renal capsule of immunocompetent mice.. In Vivo. 6(1):33-40.

Tsao CS.  1991.  Inhibiting effect of ascorbic acid on the growth of human mammary tumor xenografts.. Am J Clin Nutr. 54(6 Suppl):1274S-1280S.

Harakeh S, Jariwalla RJ.  1991.  Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells.. Am J Clin Nutr. 54(6 Suppl):1231S-1235S.

Cameron E.  1991.  Protocol for the use of vitamin C in the treatment of cancer.. Med Hypotheses. 36(3):190-4.